240 results on '"De Petris L"'
Search Results
2. P2.10-04 Real-World Outcome of Metastatic ALK-Positive Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
3. Management of brain metastasized non-small cell lung cancer (NSCLC) – From local treatment to new systemic therapies
4. A Comparative Analysis between Real-World Data and Clinical Trials to Evaluate Differences in Outcomes for SCLC Patients
5. P2.13-03 Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer
6. EP.12A.10 Multi-Omics Uncovers Signatures Associated with Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients
7. Validation of the 7th and upcoming 8th TNM staging system in small cell lung cancer: 91P
8. The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer
9. FP16.04 A Nationwide Population-Based Mapping of Mutations and Gene Fusions in Lung Cancer Among Never-Smokers
10. A Nationwide Population-Based Mapping of Mutations and Gene Fusions in Lung Cancer Among Never-Smokers
11. 63MO Safety analysis of durvalumab following stereotactic body radiotherapy (SBRT) in early-stage non-small cell lung cancer (NSCLC) patients: A first report of a randomized phase II trial (ASTEROID)
12. Renal mass dosing and graft function in children transplanted from pediatric donors
13. Second-line chemotherapy for non-small cell lung cancer
14. Treatment of advanced non-small cell lung cancer
15. Locally advanced non-small cell lung cancer: role of induction chemotherapy in resectable N2 disease
16. Genes and variants in hematopoiesis-related pathways are associated with gemcitabine/carboplatin-induced thrombocytopenia
17. Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
18. P2.01-27 Apparent Diffusion Coefficient (ADC) Change on Repeated Diffusion-Weighted MRI During Chemotherapy for Stage IV Lung NSCLC
19. P2.10-01 Analysis of Human Papilloma Viruses (HPV) and Human Polyoma Viruses (HPyV) in Lung Cancer from Swedish Never-Smokers
20. P2.12-06 Factors of Importance for Survival After Platinum Re-Challenge in Platinum-Sensitive Small-Cell Lung Cancer Patients
21. P1.14-37 Lung Cancer in Never-Smokers: A Nationwide Population Based Mapping of Targetable Alterations
22. P3.09-05 Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
23. P2.13-02 ALK-Translocation and Brain Metastases: A Retrospective Study. Correlation Between Clinical Outcome, Disease Burden and Management.
24. P3.12-17 A Retrospective Study Examining the Role of PET-CT in the 8th TNM Staging System of SCLC
25. MA21.07 A Nation-Wide Population-Based Mapping of Targetable Alterations in Smoking-Independent Lung Cancer
26. A Nation-Wide Population-Based Mapping of Targetable Alterations in Smoking-Independent Lung Cancer
27. P2.02-042 Clinical Significance of the Tumor Expression of PD-L1 Using Four Immunohistochemistry Assays in Non-Small Cell Lung Cancer. Multicentre Study
28. P2.02-043 Multicenter Assessment of PD-L1 Immunohistochemistry: Challenges for Establishing the Concordance Between Four Different Antibodies
29. P1.01-074 Exosomal RNA-Profiling of Lung Pleural Effusions Identifies Adenocarcinoma Patients through Elevated miR-200 Expression
30. Second-line treatment of advanced non-small cell lung cancer
31. Second-line treatment of advanced non-small lung cancer
32. Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)
33. 91P: Validation of the 7th and upcoming 8th TNM staging system in small cell lung cancer
34. Two cases of neonatal adrenal hemorrhage presenting with persistent jaundice
35. Trimming long-term tunneled central venous catheters in pediatric patients
36. Tumori del polmone e della pleura
37. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine
38. Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis
39. Lung abscess in a child secondary to Mycoplasma pneumoniae infection
40. IL CARCINOMA PAPILLARE SIEROSO DEL PERITONEO: CASO CLINICO
41. A case of mesothelioma of the tunica vaginalis testis, with involvement of the pleura and peritoneum
42. Plasma metabolomics in non-small-cell lung cancer
43. 1263P - Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)
44. Two cases of neonatal adrenal hemorrhage presenting with persistent jaundice
45. Chronic Massive Fetomaternal Hemorrhage in a newborn from immigrants. Clinical and organizational implications
46. 1099 POSTER Plasma Metabolomics in Non-small-cell Lung Cancer
47. 347 INVITED Cancer Proteomics – From low Resolution to High Resolution to Study Lung Cancer Phenotype
48. The Impact of HMI on the Design of a Disassembly System
49. Bone morphogenetic protein-7 delays podocyte injury due to high glucose
50. An alternative schedule of oral vinorelbine tested as 2nd-line treatment on elderly patients with advanced non-small cell lung cancer (NSCLC): A phase I feasibility trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.